Screener
Editas Medicine EDIT Q2 2025 earnings
Reported August 12, 2025 · Before market open
Revenue$3.6MBeat by $1.8M
EPS-$0.63Miss by $0.22
Revenue estimate$1.8M
EPS estimate-$0.41
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$4.5M
EPS estimate-$0.21
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Editas Medicine report Q2 2025 earnings?
- Editas Medicine (EDIT) reported Q2 2025 earnings on August 12, 2025 before market open.
- What were Editas Medicine's Q2 2025 revenue and EPS?
- Editas Medicine reported revenue of $3.6M and eps of $-0.63 for Q2 2025.
- Did Editas Medicine beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $1.8M by $1.8M. EPS missed the consensus estimate of $-0.41 by $0.22.
- How did Editas Medicine's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 597.5% from $513.0K a year earlier and eps grew 23.2% from $-0.82.
- Where can I find Editas Medicine's Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001650664-25-000123) and the 10-Q periodic report (0001650664-25-000125) directly on SEC EDGAR. The filing index links above go to sec.gov.
